Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Inner Medicine 1, Heidelberg, Germany; Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.
Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.
Mol Aspects Med. 2019 Aug;68:90-100. doi: 10.1016/j.mam.2019.07.001. Epub 2019 Jul 16.
For the past decade, brown adipose tissue (BAT) has been extensively studied as a potential therapy for obesity and metabolic diseases due to its thermogenic and glucose-consuming properties. It is now clear that the function of BAT goes beyond heat production, as it also plays an important endocrine role by secreting the so-called batokines to communicate with other metabolic tissues and regulate systemic energy homeostasis. However, despite numerous studies showing the benefits of BAT in rodents, it is still not clear whether recruitment of BAT can be utilized to treat human patients. Here, we review the advances on understanding the role of BAT in metabolism and its benefits on glucose and lipid homeostasis in both humans and rodents. Moreover, we discuss the latest methodological approaches to assess the contribution of BAT to human metabolism as well as the possibility to target BAT, pharmacologically or by lifestyle adaptations, to treat metabolic disorders.
在过去的十年中,棕色脂肪组织(BAT)因其产热和消耗葡萄糖的特性而被广泛研究作为肥胖和代谢疾病的潜在治疗方法。现在很清楚,BAT 的功能不仅仅是产热,因为它还通过分泌所谓的 batokines 来发挥重要的内分泌作用,与其他代谢组织进行通讯并调节全身能量平衡。然而,尽管有大量研究表明 BAT 在啮齿动物中的益处,但仍不清楚是否可以招募 BAT 来治疗人类患者。在这里,我们回顾了理解 BAT 在代谢中的作用及其对人类和啮齿动物葡萄糖和脂质稳态的益处的最新进展。此外,我们还讨论了评估 BAT 对人类代谢贡献的最新方法,以及通过药理学或生活方式适应来靶向 BAT 以治疗代谢紊乱的可能性。